131 related articles for article (PubMed ID: 30496824)
1. The cAMP/PKA Pathway Inhibits Beta-amyloid Peptide Release from Human Platelets.
Sepúlveda C; Hernández B; Burgos CF; Fuentes E; Palomo I; Alarcón M
Neuroscience; 2019 Jan; 397():159-171. PubMed ID: 30496824
[TBL] [Abstract][Full Text] [Related]
2. Platelets contribute to amyloid-β aggregation in cerebral vessels through integrin αIIbβ3-induced outside-in signaling and clusterin release.
Donner L; Fälker K; Gremer L; Klinker S; Pagani G; Ljungberg LU; Lothmann K; Rizzi F; Schaller M; Gohlke H; Willbold D; Grenegard M; Elvers M
Sci Signal; 2016 May; 9(429):ra52. PubMed ID: 27221710
[TBL] [Abstract][Full Text] [Related]
3. Amyloid β-peptide-dependent activation of human platelets: essential role for Ca2+ and ADP in aggregation and thrombus formation.
Canobbio I; Guidetti GF; Oliviero B; Manganaro D; Vara D; Torti M; Pula G
Biochem J; 2014 Sep; 462(3):513-23. PubMed ID: 24984073
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway.
Wang QW; Rowan MJ; Anwyl R
Neurobiol Aging; 2009 Oct; 30(10):1608-13. PubMed ID: 18272254
[TBL] [Abstract][Full Text] [Related]
5. Relevance of N-terminal residues for amyloid-β binding to platelet integrin α
Donner L; Gremer L; Ziehm T; Gertzen CGW; Gohlke H; Willbold D; Elvers M
Cell Signal; 2018 Oct; 50():121-130. PubMed ID: 29964150
[TBL] [Abstract][Full Text] [Related]
6. Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C.
Skovronsky DM; Lee VM; Praticò D
J Biol Chem; 2001 May; 276(20):17036-43. PubMed ID: 11278299
[TBL] [Abstract][Full Text] [Related]
7. Amyloid β peptide stimulates platelet activation through RhoA-dependent modulation of actomyosin organization.
Sonkar VK; Kulkarni PP; Dash D
FASEB J; 2014 Apr; 28(4):1819-29. PubMed ID: 24421399
[TBL] [Abstract][Full Text] [Related]
8. Prolonged inhibition of protein kinase A results in metalloproteinase-dependent platelet GPIbalpha shedding.
Dai K; Yan R; Li S; Fan Y; Zhuang F; Ruan C
Thromb Res; 2009 May; 124(1):101-9. PubMed ID: 19181367
[TBL] [Abstract][Full Text] [Related]
9. Release of beta-amyloid from high-density platelets: implications for Alzheimer's disease pathology.
Casoli T; Di Stefano G; Giorgetti B; Grossi Y; Balietti M; Fattoretti P; Bertoni-Freddari C
Ann N Y Acad Sci; 2007 Jan; 1096():170-8. PubMed ID: 17405928
[TBL] [Abstract][Full Text] [Related]
10. G protein and cAMP-dependent protein kinase mediate amyloid beta-peptide inhibition of neuronal glucose uptake.
Prapong T; Uemura E; Hsu WH
Exp Neurol; 2001 Jan; 167(1):59-64. PubMed ID: 11161593
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of P-selectin expression by protein kinase A and protein kinase G in thrombin-stimulated human platelets.
Libersan D; Rousseau G; Merhi Y
Thromb Haemost; 2003 Feb; 89(2):310-7. PubMed ID: 12574812
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters.
Toneff T; Funkelstein L; Mosier C; Abagyan A; Ziegler M; Hook V
Peptides; 2013 Aug; 46():126-35. PubMed ID: 23747840
[TBL] [Abstract][Full Text] [Related]
13. Blood platelets in the progression of Alzheimer's disease.
Gowert NS; Donner L; Chatterjee M; Eisele YS; Towhid ST; Münzer P; Walker B; Ogorek I; Borst O; Grandoch M; Schaller M; Fischer JW; Gawaz M; Weggen S; Lang F; Jucker M; Elvers M
PLoS One; 2014; 9(2):e90523. PubMed ID: 24587388
[TBL] [Abstract][Full Text] [Related]
14. Possible role of calpain in normal processing of beta-amyloid precursor protein in human platelets.
Chen M; Durr J; Fernandez HL
Biochem Biophys Res Commun; 2000 Jun; 273(1):170-5. PubMed ID: 10873581
[TBL] [Abstract][Full Text] [Related]
15. Identification of post-translational modifications of Aβ peptide in platelet membranes from patients with cerebral amyloid angiopathy.
Song L; Xue R; Ge P; Li M; Wang L; Zheng F; Zhao L; Wang Z; Wang Z; Wang Q; Liu N; Sun X
J Neurol Sci; 2017 Dec; 383():11-17. PubMed ID: 29246595
[TBL] [Abstract][Full Text] [Related]
16. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
Russo I; Doronzo G; Mattiello L; De Salve A; Trovati M; Anfossi G
Thromb Res; 2004; 114(4):265-73. PubMed ID: 15381390
[TBL] [Abstract][Full Text] [Related]
17. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor α promotes non-amyloidogenic processing of platelet amyloid precursor protein via the MAPK/ERK pathway.
Shi C; Zhu X; Wang J; Long D
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():280-5. PubMed ID: 25017047
[TBL] [Abstract][Full Text] [Related]
19. Intracellular cyclic AMP inhibits constitutive and phorbol ester-stimulated secretory cleavage of amyloid precursor protein.
Efthimiopoulos S; Punj S; Manolopoulos V; Pangalos M; Wang GP; Refolo LM; Robakis NK
J Neurochem; 1996 Aug; 67(2):872-5. PubMed ID: 8764618
[TBL] [Abstract][Full Text] [Related]
20. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets.
Hayashi H; Sudo T
Thromb Haemost; 2009 Aug; 102(2):327-35. PubMed ID: 19652884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
